Fortress Biotech (FBIOP) Competitors

$5.60

+0.42 (+8.11%)

(As of 10/17/2024 ET)

FBIOP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, ACABU, BFRIW, BTMDW, and BCTXW

Should you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Fortress Biotech vs.

Fortress Biotech (NASDAQ:FBIOP) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking.

: Company Net Margins Return on Equity Return on Assets
Fortress Biotech N/A N/A N/A
180 Life Sciences N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fortress Biotech $82.62M N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: Fortress Biotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
Fortress Biotech N/A N/A
180 Life Sciences N/A N/A
: In the previous week, 180 Life Sciences' average media sentiment score of 1.89 beat Fortress Biotech's score of 0.43 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Company Overall Sentiment
Fortress Biotech Neutral
180 Life Sciences Very Positive
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortress Biotech
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
Fortress Biotech	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortress Biotech	$82.62M	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
Fortress Biotech	N/A	N/A
180 Life Sciences	N/A	N/A

Company	Overall Sentiment
Fortress Biotech	Neutral
180 Life Sciences	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortress Biotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Fortress Biotech and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

Ad Porter & Company

The most serious warning of my career

With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Click here now to grab your seat now.

Get Fortress Biotech News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FBIOP vs. The Competition

Export to Excel

Metric	Fortress Biotech	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$3.76B	$5.62B	$8.49B
Dividend Yield	12.11%	3.33%	4.64%	4.11%
P/E Ratio	N/A	304.86	139.04	20.32
Price / Sales	N/A	9,632.95	1,228.28	89.22
Price / Cash	N/A	14.06	38.69	33.60
Price / Book	N/A	6.70	4.89	4.66
Net Income	N/A	$56.56M	$120.24M	$227.46M
7 Day Performance	9.80%	9.16%	3.33%	3.35%
1 Month Performance	-1.93%	32.73%	16.51%	11.68%
1 Year Performance	-51.47%	36.68%	32.69%	27.61%

Fortress Biotech Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
FBIOP Fortress Biotech	N/A	$5.60 +8.1%	N/A	-51.8%	$0.00	$82.62M	186
ATNFW 180 Life Sciences	N/A	$0.01 flat	N/A	+38.2%	$0.00	N/A	7	Positive News
LBPSW 4D pharma	N/A	$0.04 -25.7%	N/A	N/A	$0.00	$522,000.00	N/A	Gap Down
AEHAW Aesther Healthcare Acquisition	N/A	$0.16 +6.2%	N/A	-58.1%	$0.00	N/A	2	Gap Up
AIMDW Ainos	N/A	$0.05 -3.6%	N/A	N/A	$0.00	$65,122.00	40	Positive News Gap Up High Trading Volume
ALVOW Alvotech	N/A	$2.91 -0.3%	N/A	+70.0%	$0.00	$306.77M	4	Positive News
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.05 +17.1%	N/A	-58.2%	$0.00	N/A	4	Positive News Gap Up
ACABU Atlantic Coastal Acquisition Corp. II	N/A	$11.50 flat	N/A	+13.5%	$0.00	N/A	4	Positive News
BFRIW Biofrontera	N/A	$0.02 -9.9%	N/A	N/A	$0.00	$35.24M	70	Positive News Gap Down
BTMDW biote	N/A	$1.61 +15.8%	N/A	-45.0%	$0.00	$187.23M	N/A	Gap Up
BCTXW BriaCell Therapeutics	N/A	$0.34 -5.6%	N/A	-82.6%	$0.00	N/A	8	Gap Down High Trading Volume